Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Nasopharyngeal Carcinoma 59Squamous Cell Carcinoma of Head and Neck 55Head and Neck Neoplasms 55Prostatic Neoplasms 40Oropharyngeal Neoplasms 24Carcinoma, Non-Small-Cell Lung 23Carcinoma, Squamous Cell 21Rectal Neoplasms 19Breast Neoplasms 19Nasopharyngeal Neoplasms 14Neoplasm Metastasis 13Glioblastoma 13Carcinoma 13Esophageal Neoplasms 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 11Lung Neoplasms 11Glioma 11Esophageal Squamous Cell Carcinoma 11Sarcoma 9Radiation Injuries 8Neoplasms 8Laryngeal Neoplasms 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Tongue Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Hepatocellular 6Astrocytoma 6

Interventions

Radiotherapy 3Radiation 3Radiotherapy, Intensity-Modulated 2Fluorouracil 2Cisplatin 2toripalimab 1rocakinogene sifuplasmid 1pembrolizumab 1durvalumab 1atezolizumab 1Vaccines 1VGX-3100 1Radiosurgery 1Neoadjuvant Therapy 1Mitomycins 1Magnetic Resonance Spectroscopy 1MEDI0457 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Docetaxel 1Disulfides 1Chemoradiotherapy 1Capecitabine 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Anal Canal Carcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT06630793 2025-04-08

IMPAC

Tata Memorial Centre

Phase NA Recruiting
108 enrolled
Gastrointestinal

Anal Canal Carcinoma

NCT00754078 2016-07-06

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

AHS Cancer Control Alberta

Phase 2 Unknown
58 enrolled
Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡